These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12424008)

  • 1. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
    Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation defects: a new mechanism for muscular dystrophy?
    Grewal PK; Hewitt JE
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E; Blake DJ
    Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
    Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dystroglycan linkage and muscular dystrophy].
    Shimizu T
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
    Toda T; Kobayashi K; Takeda S; Sasaki J; Kurahashi H; Kano H; Tachikawa M; Wang F; Nagai Y; Taniguchi K; Taniguchi M; Sunada Y; Terashima T; Endo T; Matsumura K
    Congenit Anom (Kyoto); 2003 Jun; 43(2):97-104. PubMed ID: 12893968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation defects in inherited muscle disease.
    Hewitt JE; Grewal PK
    Cell Mol Life Sci; 2003 Feb; 60(2):251-8. PubMed ID: 12678490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K
    Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT
    Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy.
    Grewal PK; Hewitt JE
    Biochim Biophys Acta; 2002 Dec; 1573(3):216-24. PubMed ID: 12417403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
    Toda T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.